Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zynrelef vs Exparel for Postoperative Pain Control After Robotic Sleeve Gastrectomy
NCT06349772Phase 1Recruiting
- Sponsor
- Texas Tech University Health Sciences Center
- Start
- Nov 2024
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of bupivacaine + meloxicam and bupivacaine extended release liposome injection in postoperative pain (2 arms), sponsored by Texas Tech University Health Sciences Center. Primary endpoint: Postoperative Pain Score at 72 hours. Started Nov 2024; status: recruiting.
02
Drugs
bupivacaine + meloxicambupivacaine extended release liposome injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06349772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06349772.